These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23169430)

  • 1. Drug interactions produced by proton pump inhibitors: not simply a pH effect.
    Mullin JM; Schrogie JJ
    Clin Pharmacol Ther; 2013 Feb; 93(2):150. PubMed ID: 23169430
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to "Drug interactions produced by proton pump inhibitors: not simply a pH effect".
    Budha NR; Benet LZ; Ware JA
    Clin Pharmacol Ther; 2013 Feb; 93(2):151. PubMed ID: 23169432
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy?
    Budha NR; Frymoyer A; Smelick GS; Jin JY; Yago MR; Dresser MJ; Holden SN; Benet LZ; Ware JA
    Clin Pharmacol Ther; 2012 Aug; 92(2):203-13. PubMed ID: 22739140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proton pump inhibitors in gastro-oesophageal reflux disease: what is the further step?].
    Simon M; Zerbib F
    Presse Med; 2013; 42(7-8):1081-4. PubMed ID: 23079391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is proton pump inhibitors unresponsiveness in gastroesophageal reflux disease? How should these cases be managed?
    Çelebi A; Yılmaz H
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S71-S72. PubMed ID: 29199173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Are proton pump inhibitors effective in asthmatics with gastroesophageal reflux disease?].
    Kim JH
    Korean J Gastroenterol; 2011 Oct; 58(4):169-70. PubMed ID: 22042415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non response to proton pump inhibitors in gastroesophageal reflux disease].
    Lochner S; Kirch W
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1956. PubMed ID: 19760560
    [No Abstract]   [Full Text] [Related]  

  • 9. Impedance-pH monitoring in proton pump inhibitor resistant patients: ready for clinical application?
    Galmiche JP
    Gut; 2006 Oct; 55(10):1379-81. PubMed ID: 16966695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent reflux symptoms in the proton pump inhibitor era: the changing face of gastroesophageal reflux disease.
    Dellon ES; Shaheen NJ
    Gastroenterology; 2010 Jul; 139(1):7-13.e3. PubMed ID: 20493864
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized Controlled Trial of Transoral Incisionless Fundoplication Vs. Proton Pump Inhibitors for Treatment of Gastroesophageal Reflux Disease.
    Bell RC
    Am J Gastroenterol; 2015 Nov; 110(11):1621-3. PubMed ID: 26618423
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reflux disease. How to manage when proton pump inhibitors fail?].
    Stiefelhagen P
    MMW Fortschr Med; 2014 Aug; 156(14):30. PubMed ID: 25195395
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
    Sweis R; Anggiansah A; Wong T
    Clin Gastroenterol Hepatol; 2010 Mar; 8(3):313. PubMed ID: 19788931
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastroesophageal reflux disease: endoscopy, duration of treatment, and choice of PPI.
    Greenspan NR
    Med Health R I; 2011 Apr; 94(4):92-4. PubMed ID: 21667598
    [No Abstract]   [Full Text] [Related]  

  • 15. Which PPI?
    Med Lett Drugs Ther; 2015 Jun; 57(1471):91. PubMed ID: 26079763
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: alginates for inadequate response to a proton pump inhibitor in gastro-oesophageal reflux disease.
    Vakil N
    Aliment Pharmacol Ther; 2016 May; 43(10):1103. PubMed ID: 27072318
    [No Abstract]   [Full Text] [Related]  

  • 17. Infants and proton pump inhibitors: tribulations, no trials.
    Orenstein SR; Hassall E
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):395-8. PubMed ID: 18030202
    [No Abstract]   [Full Text] [Related]  

  • 18. The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease.
    Friedlander EA; Pallentino J; Miller SK; VanBeuge SS
    J Am Acad Nurse Pract; 2010 Dec; 22(12):674-83. PubMed ID: 21129076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No effect of proton pump inhibitors on crying and irritability in infants: systematic review of randomized controlled trials.
    Gieruszczak-Białek D; Konarska Z; Skórka A; Vandenplas Y; Szajewska H
    J Pediatr; 2015 Mar; 166(3):767-70.e3. PubMed ID: 25556017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastroesophageal reflux and proton pump inhibitors: panacea or prescription abuse?].
    Mouterde O; Bellaïche M; Dumant C; Mallet E
    Arch Pediatr; 2010 Jun; 17(6):739-40. PubMed ID: 20654868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.